惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

大猫的无限游戏
大猫的无限游戏
D
DataBreaches.Net
M
MIT News - Artificial intelligence
量子位
N
Netflix TechBlog - Medium
The Cloudflare Blog
The GitHub Blog
The GitHub Blog
P
Proofpoint News Feed
人人都是产品经理
人人都是产品经理
B
Blog RSS Feed
B
Blog
博客园_首页
博客园 - Franky
MyScale Blog
MyScale Blog
有赞技术团队
有赞技术团队
Apple Machine Learning Research
Apple Machine Learning Research
MongoDB | Blog
MongoDB | Blog
云风的 BLOG
云风的 BLOG
爱范儿
爱范儿
H
Help Net Security
Y
Y Combinator Blog
Stack Overflow Blog
Stack Overflow Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
酷 壳 – CoolShell
酷 壳 – CoolShell

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Borregaard ASA (BRGAY) Discusses BioSolutions Outlook, Ma...
SA Transcripts · 2026-06-16 · via All Articles on Seeking Alpha

Borregaard ASA (BRGAY) Discusses BioSolutions Outlook, Market Uncertainty, and Product Mix Ahead of Q2 Close June 16, 2026 8:00 AM EDT

Company Participants

Pal Ramberg - Director of Investor Relations
Per Bjarne Lyngstad - Chief Financial Officer

Presentation

Pal Ramberg
Director of Investor Relations

Good afternoon, and welcome to Borregaard's pre-close call. My name is Pal Espen Ramberg, Director of Investor Relations at Borregaard. I'm joined today by CFO, Per Bjarne Lyngstad, and we are broadcasting live from the biorefinery in Norway.

Here is the agenda for today's call. First, outlook from the latest quarterly report; secondly, currency and commodity input based on public data, and last, a Q&A session. Participants are welcome to submit questions via the chat during the call.

I will now hand over to Per Bjarne, who will present the key points from the outlook communicated in the Q1 report.

Per Bjarne Lyngstad
Chief Financial Officer

Thank you, Pal Espen, and good afternoon, everyone. I will start with reiterating the key points from the outlook for both the full year and the second quarter of 2026. And when relevant, refer to questions and comments on the outlook given in the Q&A session at the webcast we held on the -- for the first quarter on the 29th of April.

I will start with BioSolutions, where we reiterated our expected full year's sales volume of about 340,000 tonnes. The second quarter sales volume is expected to be around 90,000 tonnes, in line with what we had in the second quarter in 2025, but with a less favorable product mix this year.

We got several questions regarding BioSolutions at the webcast. The first one was about how confident we are that the weaknesses in agri and batteries are temporary. We read the current picture as a reaction to the geopolitical situation, intensified